Skip to main content
Decorative image of the AMR Learning Lounge

Viewpoints Series: Neonatal Sepsis and Group B Strep

SUMMARY

July is Group B Streptococcus (GBS) awareness month. GBS infections are a leading cause of neonatal sepsis and meningitis, and the impact of neonatal sepsis is increasing due to growing levels of antimicrobial resistance (AMR). In this article, Toni Rodriguez, RN, discusses recent findings and recommendations from both US and global health entities for the prevention and care of GBS-associated sepsis with consideration of today’s AMR landscape. 

FEATURED EXPERTS

Toni Rodriguez, RN, BSN, Associate Director, Global Medical Affairs at bioMérieux


GET STARTED

Read the Learning Lounge Exclusive Viewpoints Series article here.

Take Me There Now

Filename
LL-Viewpoints-Series_Neonatal-Sepsis-and-Group-B-Strep---Toni-Rodriguez_July2022.pdf
Size
429 KB
Format
application/pdf

Read time: 7 minutes

Download the Full Neonatal Sepsis and Group B Strep Infographic.

Download Now

Filename
22-Sepsis-GBS-Infographic_V3a.pdf
Size
1 MB
Format
application/pdf

Read time: 2 minutes


We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


Global Solutions

Conventional Media

Put your confidence in bioMérieux, with High-Quality Culture Media Backed by 60+ Years of Leadership and expertise.

U.S. bioMérieux Solutions

US Solutions

CHROMID® Culture Media

CHROMID provides clear, easy to read media that can be used by trained staff to aid in infection prevention efforts to control the spread of resistance in an institution. bioMérieux, Inc. is a partner you can work with to enhance your antimicrobial stewardship efforts – providing faster, more accurate and actionable results.

PUBLISHED BY

Learning Lounge Exclusive
July 1, 2022


SHARE THIS ARTICLE: